Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
26
DRMA Quote, Financials, Valuation and Earnings
Last price:
$2.12
Seasonality move
:
-34.61%
Day range:
$2.10 - $2.21
52-week range:
$1.58 - $23.70
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.55x
Volume:
63K
Avg. volume:
1.8M
1-year change:
-83.02%
Market cap:
$2.2M
Revenue:
--
EPS (TTM):
-$16.27
Earnings Data
Next earnings date for DRMA
--
Most recent earnings per share
-$1.65
Missed by $1.65
(Sep 30/2025)
Consensus Estimate
--
(Sep 30/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DRMA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2025 | Q4 | -- | -- | -- | -- | -- |
| 09/30/2025 | Q3 | -- | -- | -$1.65 | -- | -- |
| 06/30/2025 | Q2 | -- | -- | -$1.66 | -- | -- |
| 03/31/2025 | Q1 | -- | -- | -$0.45 | -- | -- |
| 12/31/2024 | Q4 | -- | -- | -$12.51 | -- | -- |
| 09/30/2024 | Q3 | -- | -- | -$2.04 | -- | -- |
| 06/30/2024 | Q2 | -- | -- | -$4.18 | -- | -- |
| 03/31/2024 | Q1 | -- | -- | -$7.06 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$8.14 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$8.09 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$9.43 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$34.08 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$32.52 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$47.40 | -- | -- |
| 09/27/2022 | Q2 | -- | -- | -$58.54 | -- | -- |
| 05/31/2022 | Q1 | -- | -- | -$80.06 | -- | -- |
| 02/28/2022 | Q4 | -- | -- | -$73.56 | -- | -- |
| 11/15/2021 | Q3 | -- | -- | -$123.19 | -- | -- |
| 09/27/2021 | Q2 | -- | -- | -$38.38 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$66.42 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$114.21 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$17.22 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$23.68 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$40.95 | -- | -- |
Dermata Therapeutics, Inc. Earnings Questions
-
How Much did Dermata Therapeutics, Inc. Generate in Revenue Last Quarter?
Dermata Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Dermata Therapeutics, Inc. Beat Earnings Last Quarter?
Dermata Therapeutics, Inc. announced earnings per share of -$1.65 which represents a miss of analyst forecast a -- per share.
-
Is Dermata Therapeutics, Inc. Profitable?
Dermata Therapeutics, Inc. reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Dermata Therapeutics, Inc. EPS Next Year?
Dermata Therapeutics, Inc.'s earnings are forecast to grow from -$80.32 per share to -- per share next year representing an increase of --.
-
When is Dermata Therapeutics, Inc.'s Earnings Date?
Currently, Dermata Therapeutics, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on April 10, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
65
RGC alert for Jan 9
Regencell Bioscience Holdings Ltd. [RGC] is up 8.91% over the past day.
Buy
58
KRUS alert for Jan 9
Kura Sushi USA, Inc. [KRUS] is up 0.28% over the past day.
Buy
53
PBF alert for Jan 9
PBF Energy, Inc. [PBF] is down 1.06% over the past day.
